Delivery Order SPE2DE24D0013-SPE2D626F112N

Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems, has been awarded a delivery order valued at $16,381 by the Defense Logistics Agency Medical Supply Chain for COVID-19, influenza, and respiratory syncytial virus (RSV) diagnostic supplies. The delivery order, issued on November 12, 2025, with an ultimate completion date of November 19, 2025, utilizes a firm fixed-price structure with no set-aside designation. This award represents a continuation of Cepheid's extensive partnership with the Defense Logistics Agency Medical Supply Chain, which has consistently procured diagnostic testing supplies, test kits, and reagents from the company to support federal healthcare operations.

This delivery order falls under Cepheid's established contracting relationships across multiple federal agencies, including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and the U.S. Coast Guard. Cepheid has demonstrated significant federal market penetration through its GeneXpert diagnostic platform and associated molecular testing capabilities, with particular strength in rapid detection of infectious diseases. The company's core federal role encompasses supplying diagnostic equipment, reagents, test kits, and maintenance services, with established indefinite delivery contracts valued in the tens of millions of dollars that extend through 2030, positioning Cepheid as a primary federal supplier of molecular diagnostic solutions for infectious disease detection across the military and veterans healthcare systems.